The roller-coaster ride of the 21st Century Cures Act is nearly complete, with the Senate voting 94-5 in favor on Dec. 7 in favor of the measure. It now moves on to President Obama, who said he will "sign it as soon as it reaches my desk."
While many of the pharmaceutical-related elements of the bill address a series of regulatory and R&D issues with the goal...






![Spotlight On RDCs, AOCs As Leading Novel Bioconjugates[Updated]](https://web.insights.norstella-labs.com/resizer/v2/3M7ZAWZOBNK7NG4A4WDOIFG6DU.jpg?smart=true&auth=392a1fdb3cfacb29445720c412410e598dbcc5f90f14857652cd498bd0faa0fb&width=400&height=225)
